MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

30 Oct 2015 Evaluate

Glenmark Pharmaceuticals has informed about a Press Release dated , titled ‘Glenmark Pharmaceuticals receives tentative ANDA approval for Lacosamide Tablets, 50 mg, 100 mg, 150 mg and 200 mg’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1757.40
Dr. Reddys Labs. 1179.05
Cipla 1300.25
Lupin 1950.75
Zydus Lifesciences 1110.10
View more..